However, this case already indicates such treatment possibilities exist for patients possessing KIAA1549-BRAF fusions, whether in pediatric astrocytomas or difficult to characterize sarcoma like lesions. Here, KIAA1549 is linked to astrocytoma (excluding glioblastoma).